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Abstract
Real-time PCR techniques are now commonly used for the detection of viral genomes in various human specimens and
require for validation both external and internal controls (ECs and ICs). In particular, ICs added to clinical samples are
necessary to monitor the extraction, reverse transcription, and amplification steps in order to detect false-negative results
resulting from PCR-inhibition or errors in the technical procedure. Here, we performed a large scale evaluation of the use of
bacteriophages as ICs in routine molecular diagnosis. This allowed to propose simple standardized procedures (i) to design
specific ECs for both DNA and RNA viruses and (ii) to use T4 (DNA) or MS2 (RNA) phages as ICs in routine diagnosis. Various
technical formats for using phages as ICs were optimised and validated. Subsequently, T4 and MS2 ICs were evaluated in
routine real-time PCR or RT-PCR virological diagnostic tests, using a series of 8,950 clinical samples (representing 36 distinct
specimen types) sent to our laboratory for the detection of a variety of DNA and RNA viruses. The frequency of inefficient
detection of ICs was analyzed according to the nature of the sample. Inhibitors of enzymatic reactions were detected at
high frequency in specific sample types such as heparinized blood and bone marrow (.70%), broncho-alveolar liquid (41%)
and stools (36%). The use of T4 and MS2 phages as ICs proved to be cost-effective, flexible and adaptable to various
technical procedures of real-time PCR detection in virology. It represents a valuable strategy for enhancing the quality of
routine molecular diagnosis in laboratories that use in-house designed diagnostic systems, which can conveniently be
associated to the use of specific synthetic ECs. The high rate of inhibitors observed in a variety of specimen types should
stimulate the elaboration of improved technical protocols for the extraction and amplification of nucleic acids.
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Introduction
Real-time (rt) PCR and reverse transcription (RT) PCR
techniques are rapid and versatile diagnostic procedures broadly
used in clinical virology where there are mostly considered as
diagnostic ‘‘gold standards’’ [1]. Monitoring rt-PCR and rt-RT-
PCR assays and validation of the results rely on the use of relevant
external or internal controls (ECs or ICs) [1,2] and commercial
kits including such control systems are being increasingly
improved for the molecular diagnosis of a number of pathogens
such as HIV, hepatitis viruses, influenza viruses etc.. However, one
of the main strengths of rt-PCR is versatility, which provides the
opportunity to set-up ‘‘in-house’’ protocols for specific pathogens.
The scientific literature now includes an impressive number of
‘home made’’ assays for various viral agents. Whilst most
commercial kits include both ICs and ECs allowing accurate
validation of the results [3], ‘‘home made tests’’ are frequently
performed in the absence of ICs and therefore without any
possible individual monitoring of each diagnostic reaction. For
example, the detection of technical errors or PCR amplification
inhibitors is intrinsically impossible if only ECs are used. In
addition, ECs are usually undistinguishable from the native
genome.
Here, our objective was to develop and test on a large number
of clinical samples a bacteriophage-based IC system suitable for a
standard laboratory of medical virology. We present results
obtained by using T4 and MS2 bacteriophages as ICs in a
routine-based evaluation including 8,950 clinical specimens,
representing 36 types of samples, submitted for PCR detection
of selected viruses including DNA viruses (Herpesviridae, JC and BK
viruses, parvovirus B19, adenoviruses) and RNA viruses (entero-
virus, influenza virus, respiratory syncytial virus, human metap-
neumovirus, rhinovirus, Toscana virus, West Nile virus, lympho-
cytic choriomeningitidis virus, dengue virus, chikungunya virus).
Materials and Methods
1. External controls (ECs)
Important criteria for the design of ECs include (i) the possibility
to use quantified or semi quantified controls (in order to manage
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distinguish amplicons obtained from ECs from those obtained
from the detected pathogen (in order to detect false positives due
to accidental amplification of EC) and (iii) the use of relevant
nucleic acids (ie, RNA and DNA molecules for RNA and DNA
viruses, respectively).
Simple protocols for preparing plasmid DNA or synthetic RNA
quantified controls are described in Supporting Information S1
and schematised in figure 1. Such controls include specific
sequences for the hybridisation of detection primers and probe,
but also an exogenic ‘‘Not I’’ sequence (detectable by a specific
probe or cleavable by the Not I restriction enzyme).
2. Internal controls (ICs)
2a. rt-PCR assays for the detection of T4 and MS2
bacteriophages. The criteria to be addresses regarding ICs
were: (i) to monitor all steps of the diagnostic procedure
(extraction, RT, PCR); (ii) to be amenable for DNA and RNA
viruses ; (iii) to rely on a detection system specific of the phage(s) to
avoid complex molecular constructs; (iv) to be usable in either
Figure 1. Design of synthetic external controls and sequences of NOT I probe,T7 promoter primer and M13 primers.
doi:10.1371/journal.pone.0016142.g001
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reactions.
We used freeze-dried E. coli Enterobacteria phage T4 (T4) and
Enterobacteria phage MS2 (MS2) obtained from the American
Type Culture Collection (ATCC ref. 11303-B4 & 15597-B1,
respectively). Protocols for real time PCR detection of phages TA
and MS2 were elaborated in various formats and are described in
Supporting Information S2. Briefly, primers and probes targeting
T4 phage (T4F CCATCCATAGAGAAAATATCAGAACGA,
T4R TAAATAATTCCTCTTTTCCCAGCG, T4probe VIC-
AACCAGTAATTTCATCTGCTTCTGATGTGAGGC-TAM-
RA) and MS2 phage (MS2F CTCTGAGAGCGGCTCTATTGGT,
MS2R GTTCCCTACAACGAGCCTAAATTC, MS2probe VIC-
TCAGACACGCGGTCCGCTATAACGA-TAMRA) were desig-
ned from genomic sequences. Optimised oligonucleotide concentra-
tions were 10pmol for primers and 4pmol for probes for both T4 and
MS2 detection assays.
2b. Spiking and validation procedures. A suspension of
T4 and MS2 phages was used for spiking clinical samples. Both
phages were diluted to provide a similar level of detection by rt-
PCR.
The following format was used:
(i) Ten microlitres of a solution ‘‘T4 + MS2’’ were added to
200mL of sample
(ii) The dilution of phages was adjusted to provide a Cycle
threshold (Ct) at 30 for both the T4 and MS2 real time PCR
assays upon extraction and amplification of 200mL of PBS
spiked with the phage mix.
The influence of spiking on the performance of viral nucleic
acid extraction was evaluated by comparing detection of
enterovirus (echovirus 30) and cytomegalovirus (CMV) in serial
dilutions of cell cultures supernatant spiked or not spiked with
phages (see Supporting Information S3).
Similarly, the influence of spiking on the sensitivity of rt-PCR
detection was evaluated by comparing detection of enterovirus
(EV) and CMV in serial dilutions of cell culture supernatant media
and a series of positive clinical samples spiked with T4-MS2 mix in
either Two-step or One-step rt-PCR format (see Supporting
Information S4).
2. Routine application
2a. Clinical samples. From January 2007 to May 2008, a
total of 8,950 clinical specimens received in the virology laboratory
of the Public Hospitals of Marseille with a demand of PCR
detection for at least one of the viruses listed in Table 1 were
included in the study.
The approval of the relevant Ethics Committee (IFR48,
Marseilles, France) was obtained for investigating the benefit of
using phage spiking, but individual consent from patients was not
required since French national regulations under the term of
Biomedical Research (Loi Huriet-Se ´rusclat (loi 881138)) indicate
that the signature at the hospital entrance office warrants that all
samples taken during hospitalization for diagnostic purposes are
accessible for research (excluding human genetic research) without
the specific consent of the patient.
2b. Spiking and rt-PCR assays. A 200ml volume of each
8,950 clinical specimens was spiked (according to the procedure
described above) before extraction which was performed onto the
MagNA Pure LC instrument (Roche) using the High Pure Viral
Nucleic Acid Kit (DNA extraction) or the MagNA Pure LC RNA
isolation High Performance kit (RNA extraction) according to
manufacturer’s recommendations. CSF, amniotic fluids, biopsy
tissues, effusions and aqueous humor were processed for
DNA+RNA extraction using the BioRobot EZ1 with the Virus
Mini Kit v2.0 (both from Qiagen). Reverse transcription was
performed for RNA viruses using the TaqMan Reverse
Transcription Reagents kit (Roche) and random hexanucleotides
as per manufacturer’s instructions. For each specimen: (i) rt-PCR
Table 1. PCR systems used for the detection of DNA or RNA viruses.
Virus Authors Reference
Herpes Simplex Virus (HSV) Kessler et al. [9] J Clin Microbiol 2000
Varicella Zona Virus (VZV) in house Unpublished
Cytomegalovirus (CMV) Griscelli et al. [10] J Clin Microbiol 2001
Human Herpes Virus 6 (HHV6) Locatelli et al. [11] J Clin Microbiol 2000
Human Herpes Virus 8 (HHV8) Lallemand et al. [12] J Clin Microbiol 2000
Adenovirus Adenovirus R-gene
TM (Argene) /
JC virus Whiley et al. [13] J Clin Microbiol 2001
BK virus Whiley et al. [13] J Clin Microbiol 2001
Parvovirus B19 Abeham et al. [14] J Virol Methods 2001
Enterovirus Watkins-Riedel T et al. [15] Diagn Microbiol Infect Dis. 2002
Chikungunya virus Pastorino et al. [16] J Virol Methods 2005
Influenza A and B virus Van Elden et al. [17] J Clin Microbiol 2001
Respiratory Syncitial Virus (RSV) Van Elden et al. [18] J Clin Microbiol 2003
Choriomeningitis Lymphocytic virus (CML) in house Unpublished
Rhinovirus Garbino et al. [19] Am J Respir Crit Care Med 2004
Toscana virus Pe ´rez-Ruiz et al. [20] J Clin Virol 2007
West Nile Virus (WNV) Lanciotti et al. [21] J Clin Microbiol 2000
Dengue virus Leparc-Goffart et al. [22] J Clin Virol 2009
doi:10.1371/journal.pone.0016142.t001
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(Table 1), and (ii) distinct rt-PCR reactions for detection of T4 or
MS2 were performed under a 15 mL reaction format (7,5 mLo f
mastermix, 3 pmol of each primer and 1,2 pmol of probe) and a
standard cycling protocol (50uC for 2 min, 95uC for 10 min and
45 cycles 95uC for 15 sec, 60uC for 1 min).
2c. Interpretation of results. For each series of T4 and
MS2 rt–PCR, the mean Ct value and the standard deviation
within the series were calculated. Each individual reaction was
subsequently analysed as follows:
(i) If the Ct value was equal to or lower than the mean Ct value
of the series +1SD, it was recorded as ‘‘correct detection of
the phage’’ (CDP), and associated with the absence of
detectable inhibitor or technical problem while processing
the corresponding sample.
(ii) If the Ct value was higher than the mean Ct value of the
series +1SD (or undetectable), it was recorded as ‘‘inefficient
detection of the phage’’ (IDP), and associated with the
presence of amplification inhibitor(s) or technical problem
while processing the corresponding sample.
N When IDP was associated with a positive PCR (detection
of a pathogen), this result was validated despite the
presence of inhibitors (this would not apply to the case in
which quantification of viral load is necessary).
N When IDP was associated with negative PCR detection
results, a new assay was performed using a tenfold dilution
of the nucleic acid extract. All negative results were
considered unresolved (UNR). Positive results were
validated.
Results
1. Optimization and validation of procedures
The detection of EV and CMV in serial dilutions of supernatant
cell culture media or in series of positive clinical samples spiked
with T4-MS2 mix was performed and the comparison of the Ct
values showed that neither the addition of the phage mix itself
(Wilcoxon test, p=0.18 for CMV and 0.45 for EV), nor the
presence of phage-specific primers and probe in the reaction mix
(Wilcoxon test, p=0.77 for CMV and 0.18 for EV) did interfere
with the Ct value associated with viral detection in Two-step
(Table 2 and 3) and One-step rt-PCR.
2. Phage spiking in routine rt-PCR virological diagnosis
During the period of study, 8,950 clinical samples were spiked
with phages and tested: 7,397 for the presence of DNA viruses
only, 337 for the presence of RNA viruses only and 1,216 for both,
corresponding to a total of 45,530 results transmitted to the
prescribers (see details in Figure 2).
Inhibitors could be detected for all types of samples, but with
highly variable rates (analysis performed for series including a
minimum of 10 samples): less than 10% in the case of pleural
effusions and sputum samples, genital and pharynx swabs, lymph
nodes and placentas; 10% to 30% for EDTA whole blood, white
blood cells, sera, biopsies, pericardial and peritoneal effusions,
bronchial aspiration, CSF, amniotic fluids, others swabs, urine,
aqueous humor and culture cells; 30% to 50% for plasma, BAL
and stools; more than 50% for heparinized plasma and bone
marrow.
IDPs were significantly more frequently detected for MS2
(RNA) than T4 (DNA) in plasma, BAL and CSF samples (p,0.05,
Khi2 test, Yates corrected). Conversely, IDPs were significantly
more frequently detected for T4 than MS2 in stools (p,0.05, Khi2
test, Yates corrected).
Finally, it was noted that clinical samples stored at 280uC prior
extraction exhibited an IDP rate lower than 30%.
Discussion
Rt-PCR and rt-RT-PCR techniques are now widely used for
the molecular diagnosis of viral infections. Our study was focused
on the importance of quality controls for such diagnostic assays.
We proposed a simple protocol for synthesizing specific external
controls which combines standard techniques for obtaining
quantified DNA or RNA positive controls. Importantly, these
controls were designed to include an extrinsic sequence that
contains a (very rare) cutting site for the NotI restriction enzyme.
This provides a simple tool for using adapted and reproducible
amounts of positive controls, and also for identifying PCR
contamination due to carry over of the positive control. This
detection can be performed by real time amplification using the
specific Not I probe (Figure 1) or following gel analysis after
restriction by NotI.
Dreier et al. (2005,2006), Rolfe et al. (2007) and Gerriets et al.
(2008) previously evaluated the use of MS2 or T4 ICs for testing
limited series of sera, cerebrospinal fluids and stools [4,5,6,7]. Our
study confirms that the performance of ‘home made’ tests can be
significantly improved by the used of phage-based internal
controls, but, most importantly, shows that such controls can be
used for routine virological diagnosis and usable for a variety of
clinical samples. Here, clinical samples were spiked with both T4
and MS2 phages, allowing the detection of inhibitors for both
DNA and RNA viruses. Thirty-six different types of clinical
samples were tested (including various blood samples, cerebrospi-
Table 2. Influence of spiking on the performance of viral nucleic acid purification.
Virus Unspiked specimen (A) IC spiked specimen (B) Wilcoxon test
a CMV 10
23 33.6 33.8 NS
CMV 10
24 36.3 36.6 NS
CMV 10
25 39.6 39.4 NS
bE V 1 0
23 30.1 30.6 NS
EV 10
24 33.7 33.8 NS
EV 10
25 38.2 37.8 NS
Cycles Thresholds (Ct) of serial dilutions of supernatant media of CMV (a) or EV (b) cell cultures unspiked (A) or spiked (B) with T4-MS2 IC were presented here. Each
samples were tested in triplicate (the mean value was calculated). The Wilcoxon test were used to compared Ct values (NS=non significative).
doi:10.1371/journal.pone.0016142.t002
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fluids) and a large number of samples were tested in the context of
an hospital routine molecular virology laboratory. The use of
phages as internal controls proved to be extremely versatile and
could be adapted to a broad range of methods and pathogens. It
was validated for both PCR and RT-PCR real time techniques, in
simplex or multiplex format and, in the case of RT-PCR assays,
one-step or two-step amplification formats. In addition, whilst the
current report relies on probe-based real time amplification
techniques, the method could also be conveniently adapted to a
real time SYBR Green detection assay [8]. This is important and
suggests that a strategy including phage-based internal controls
Table 3. Influence of spiking on the performance of viral nucleic acid detection.
Virus CMV or EV detection system alone (A) Multiplex system (B) Wilcoxon test
a CMV 10
23 33.9 33.8 NS
CMV 10
24 36.7 37.0 NS
CMV 10
25 39.8 39.5 NS
bE V 1 0
23 30.7 30.8 NS
EV 10
24 33.9 33.8 NS
EV 10
25 38.3 37.9 NS
Serial dilutions of supernatant media of CMV (a) or EV (b) cell cultures spiked with T4-MS2 IC were tested either with the CMV or EV detection system alone (A) or the
multiplex system (B). All cycles Thresholds (Ct) were presented here. Each samples were tested in triplicate (the mean value was calculated). The Wilcoxon test were
used to compared Ct values (NS=non significative).
doi:10.1371/journal.pone.0016142.t003
Figure 2. Results of the routine hospital use of bacteriophage ICs. MP (MagNA Pure LC instrument extraction), EZ1 (BioRobot EZ1 extraction).
N (Number of samples), IDP (Inefficient detection of the phage). Results represent the number of PCR tests performed for each type of samples. Series
with less than 10 samples are no highlighted. Samples with less than 10% of IDPs are highlighted in yellow, between 10 and 30% of IDPs in orange,
between 30 and 50% of IDPs in pink and more than 50% of IDPs in red.
doi:10.1371/journal.pone.0016142.g002
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technical characteristics of the amplification methods used for
routine tests. In our experience, the simplex format strategy (i.e.
based on testing phages and viral pathogens in distinct
amplification reactions) proved to be the most simple and cost-
effective for routine molecular diagnosis since it does not require
the specific development of multiplex reactions and relies on a
unique control reaction for DNA viruses and another for RNA
viruses.
Our study identified different frequencies of inhibitors accord-
ing to the nature of the clinical samples. In samples such as CSF,
sera or pharynx swabs, inhibitors were identified in ,10% and
,15–20% for DNA and RNA virus detection, respectively. These
values are unexpectedly high, and imply that a significant number
of samples with results believed to be ‘‘negative’’ in the absence of
an internal control should be considered ‘‘unresolved’’. Specific
samples such as heparinized blood (72,9% of inhibitors for DNA
virus detection), bone marrow (73.8% of inhibitors for DNA virus
detection) and stools (36.6% and 20.8% of inhibitors for DNA and
RNA viruses detection, respectively) may also benefit from the
detection of inhibitors and the identification of ‘‘unresolved’’ tests.
It should be noted that the frequency of amplification inhibition
not only relates to the nature of the sample tested, but is also
intrinsically linked with the technical protocols used for the
extraction and amplification of nucleic acids. In our experience, no
major differences were observed when different silica column- or
magnetic beads- based extraction techniques, or different
commercialized PCR or RT-PCR kits, were tested (data not
shown). However, a detailed analysis may reveal that specific
techniques give better results when used for testing specific
samples. We suggest that, in the future, phage-based internal
controls may constitute cost-effective tools with which to measure
the frequency of amplification inhibition in specific samples.
Estimation of this parameter may become a major criterion for the
evaluation of extraction (and to a lesser extent amplification)
techniques.
Finally, in the context of diagnostic virology laboratories, our
study shows that standard extraction and amplification techniques
used for the molecular diagnosis of human pathogens led to a
significant proportion of ‘unresolved’ results, which cannot be
identified if an internal control is not used. In the absence of an
internal control, such samples are commonly identified as
‘negative’, which is with hindsight incorrect: in our hands,
detecting amplification inhibition using phages as internal
controls, and testing tenfold dilutions of the nucleic acid extracts
demonstrated that some of these samples were actually positives.
This cost-effective and convenient strategy can therefore be used
for enhancing the quality of routine molecular diagnosis, but it
may also be adapted in other contexts such as testing of large
numbers of animal or environmental samples.
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